![]() |
市场调查报告书
商品编码
1967691
止血带系统市场-全球产业规模、份额、趋势、机会、预测:按组件、最终用户、地区和竞争对手划分,2021-2031年Tourniquet Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Tourniquet Instrument, Tourniquet Cuffs), By End user, By Region & Competition, 2021-2031F |
||||||
全球止血带系统市场预计将从 2025 年的 5.3809 亿美元成长到 2031 年的 6.9352 亿美元,复合年增长率为 4.32%。
这些气动和非气动医疗设备旨在暂时阻断流向四肢的动脉血流,从而为外科医生创造无血手术环境,并防止紧急创伤治疗期间的出血。市场成长的主要驱动力是整形外科和重建手术数量的增加,以及全球人口老化导致跌倒和骨折等损伤需要手术修復。此外,军方不断增加的用于提升战场止血能力的支出也持续推动对临床和战场止血带解决方案的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 5.3809亿美元 |
| 市场规模:2031年 | 6.9352亿美元 |
| 复合年增长率:2026-2031年 | 4.32% |
| 成长最快的细分市场 | 止血袖口 |
| 最大的市场 | 北美洲 |
阻碍市场扩张的主要障碍之一是长期使用或误用止血袖带可能导致的临床併发症,例如神经麻痹和组织坏死。这些安全风险通常会导致严格的监管和法律责任问题,这可能会延缓该设备在非紧急情况下的应用。儘管如此,人们对这些技术的依赖程度仍然很高。根据美国整形外科学会统计,到2024年,美国关节重建登记处报告的髋关节和膝关节手术累积总数将超过370万例,这一数据凸显了外科手术对这些止血技术的高度依赖,以确保手术的精准性。
整形外科和关节重建手术数量的不断增长是全球止血带系统市场的主要驱动力。随着人口老化,关节成形术和重组手术的需求日益增长,对止血装置的需求也显着增加,以确保手术视野无血。这些系统对于维持手术精确度和最大限度减少复杂肢体手术的併发症至关重要。这一趋势也体现在主要企业的财务表现中。根据强生公司于2025年1月发布的“2024财年业绩报告”,该公司整形外科销售额达到91亿美元。这数字显示手术辅助器械的使用率持续高涨,也与医院持续购买气动止血带系统密切相关。
此外,全球创伤和交通事故发生率的上升正在加速市场成长,尤其是在院前急救领域。高速撞击伤需要快速止血,因此部署可靠的现场止血带至关重要。根据美国国家公路交通安全管理局 (NHTSA) 于 2025 年 4 月发布的“2024 年交通事故死亡初步估计”,预计美国交通事故死亡人数将达到 39,345 人,凸显了有效创伤治疗工具的重要性。製造商正在寻求策略整合以满足这一需求。例如,在 2025 年 9 月题为「SAM Medical 扩展急救医疗产品线」的新闻稿中,SAM Medical 宣布收购 TyTek Medical,以扩展其急救医疗解决方案并加强其创伤治疗供应链。
神经麻痹和组织坏死等临床併发症的风险仍然是全球止血带系统市场成长的一大障碍。长时间缺血或袖带压力过大导致的不利事件往往会引起监管机构更严格的审查,并增加医疗机构的法律责任风险。因此,严格的安全通讯协定和对潜在诉讼的担忧可能会限制气动止血带系统在择期手术和非紧急手术中的应用,从而可能减缓其在已有其他止血方法的地区的市场渗透率。
这种谨慎的做法也得到了统计数据的进一步佐证,数据显示整形外科领域器械相关问题的发生率很高。据美国整形外科学会称,2024年FDA宣布的所有医疗设备召回事件中,约有20%与整形外科领域有关,这凸显了该领域持续面临的安全挑战的严峻性。如此高的召回率迫使製造商不断调整产品并遵守严格的合规标准,导致生产成本增加,并延缓了新型止血带技术的商业化。最终,与这些安全问题相关的财务和声誉风险成为市场扩张的主要限制因素。
随着医疗机构将病人安全和减少医源性损伤放在首位,个人化肢体阻断压力(LOP)技术的普及正在重塑市场格局。先进的气动系统正逐步取代标准的固定压力装置,它们利用数位演算法计算个别动脉阻断所需的最小压力,从而降低神经麻痹和软组织损伤的风险。市场领导对先进医疗和外科器械的持续需求推动,第四季度净销售额增长10.7%,达到64亿美元。
同时,手术环境中对严格感染控制通讯协定和消除交叉感染的迫切需求,正迅速推动市场转向一次性抛弃式袖套。医院正积极采购这些耗材解决方案,以简化消毒流程并满足更严格的卫生标准,尤其是在创伤和整形外科手术等高频次手术中。这种营运模式的转变也体现在专业製造商的扩张上。在2025年1月发布的题为「Ulrich Medical连续第15年实现成长」的新闻稿中,Ulrich Medical公布了2024财年的销售额为1.63亿欧元(同比增长10%),这印证了市场对感染预防医疗技术的日益增长的依赖。
The Global Tourniquet Systems Market is projected to expand from a valuation of USD 538.09 Million in 2025 to USD 693.52 Million by 2031, reflecting a CAGR of 4.32%. These pneumatic and non-pneumatic medical devices are engineered to temporarily obstruct arterial blood flow to extremities, facilitating a bloodless operative environment for surgeons or preventing exsanguination during emergency trauma care. Market growth is largely propelled by the rising number of orthopedic and plastic surgical procedures, coupled with global demographics characterized by an aging population susceptible to falls and fractures that necessitate surgical repair. Additionally, increased military expenditure focused on enhancing battlefield hemorrhage control capabilities continues to drive the demand for both clinical and field-grade tourniquet solutions.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 538.09 Million |
| Market Size 2031 | USD 693.52 Million |
| CAGR 2026-2031 | 4.32% |
| Fastest Growing Segment | Tourniquet Cuffs |
| Largest Market | North America |
One major obstacle hindering broader market growth involves the potential for clinical complications, including nerve paralysis and tissue necrosis, which can arise from extended or incorrect cuff application. These safety risks frequently result in rigorous regulatory oversight and liability concerns, potentially slowing the uptake of these devices in non-essential scenarios. However, the dependence on these technologies remains high; according to the American Academy of Orthopaedic Surgeons, in 2024, the American Joint Replacement Registry reported a cumulative total of more than 3.7 million hip and knee procedures, a statistic that underscores the substantial surgical reliance on these exsanguination technologies for operative precision.
Market Driver
The increasing volume of orthopedic and joint replacement surgeries serves as a primary engine for the global tourniquet systems market. With an aging population requiring more arthroplasty and reconstructive interventions, the demand for exsanguination devices to establish bloodless surgical fields has grown significantly, as these systems are essential for maintaining operative precision and minimizing complications in complex limb procedures. This trend is mirrored in major industry financial results; according to Johnson & Johnson, January 2025, in the 'Full Year 2024 Results', the company generated $9.1 billion in orthopedic sales, a figure that emphasizes the continued high volume of procedures utilizing these ancillary devices and correlates with the consistent hospital procurement of pneumatic tourniquet systems.
Furthermore, the rising global incidence of trauma and road traffic accidents is accelerating market growth, particularly within the pre-hospital and emergency medical sectors. High-velocity injuries demand rapid hemorrhage control, necessitating the deployment of rugged, field-ready tourniquets. According to the National Highway Traffic Safety Administration, April 2025, in the 'Early Estimates of Traffic Fatalities for 2024', it was projected that 39,345 people died in traffic crashes in the United States, underscoring the critical need for effective trauma care tools. Manufacturers are responding to this requirement through strategic consolidation; for instance, according to SAM Medical, September 2025, in the 'SAM Medical Expands Emergency Medical Offering' press release, the company announced the acquisition of TyTek Medical to broaden its emergency medical solutions, further solidifying the supply chain for trauma interventions.
Market Challenge
The potential for clinical complications, such as nerve paralysis and tissue necrosis, remains a significant barrier to the growth of the Global Tourniquet Systems Market. Adverse events caused by prolonged ischemia or excessive cuff pressure often lead to intensified regulatory oversight and increased liability risks for medical providers. As a result, the implementation of strict safety protocols and the apprehension regarding potential litigation can discourage the use of pneumatic systems in elective or non-critical surgeries, thereby slowing market penetration in segments where alternative hemostatic methods exist.
This caution is further justified by statistics indicating a high frequency of device-related problems within the orthopedic field. According to the American Academy of Orthopaedic Surgeons, in 2024, orthopaedics accounted for approximately 20 percent of all medical device recalls issued by the FDA, a statistic that underscores the persistent safety challenges facing this category. Such high recall rates compel manufacturers to undertake continuous product adjustments and adhere to rigorous compliance standards, which in turn drives up production costs and postpones the commercialization of new tourniquet technologies. Ultimately, the financial and reputational risks associated with these safety complications act as a significant restraint on broader market expansion.
Market Trends
The market is currently being reshaped by the widespread adoption of Personalized Limb Occlusion Pressure (LOP) technology, as healthcare providers prioritize patient safety and the reduction of iatrogenic injuries. Advanced pneumatic systems are progressively superseding standard fixed-pressure devices by utilizing digital algorithms to calculate the minimum pressure required for individual arterial occlusion, thereby mitigating the risks of nerve paralysis and soft tissue damage. This technological transition toward higher-precision instrumentation is evidenced by the robust financial performance of market leaders; according to Stryker, January 2025, in the 'Stryker Reports 2024 Operating Results and 2025 Outlook' press release, the company announced that fourth-quarter net sales increased 10.7% to $6.4 billion, a growth trajectory partly driven by the sustained demand for sophisticated medical and surgical equipment.
Concurrently, there is a rapid market transition toward single-use sterile disposable cuffs, propelled by rigorous infection control protocols and the operational necessity to eliminate cross-contamination in surgical environments. Hospitals are aggressively procuring these consumable solutions to streamline sterile processing workflows and ensure compliance with heightened sanitary standards, particularly in high-volume trauma and orthopedic procedures. This operational pivot is reflected in the expansion of specialized manufacturers; according to Ulrich Medical, January 2025, in the 'Ulrich Medical Grows for the 15th Year in Succession' press release, the company reported a 10% revenue increase to €163 million for the 2024 financial year, underscoring the growing market reliance on infection-preventing medical technologies.
Report Scope
In this report, the Global Tourniquet Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Tourniquet Systems Market.
Global Tourniquet Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: